The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (7.61) USD. With the latest stock price at 0.80 USD, the upside of Cytosorbents Corp based on DCF is -1057.4%.
Based on the latest price of 0.80 USD and our DCF valuation, Cytosorbents Corp (CTSO) is a sell. selling CTSO stocks now will result in a potential gain of 1057.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 7.8% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (19.96) - (4.85) | (7.61) |
| Upside | -2610.8% - -710.5% | -1057.4% |